Metropolitan Dysphagia Specialists Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14810 Ashford Ct, Laurel, MD 20707 Phone: 301-327-0331 |
Sheylah Gaona, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14409 Greenview Dr Ste 102, Laurel, MD 20708 Phone: 301-498-8100 Fax: 301-498-0009 |
Samantha Theriot, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14409 Greenview Dr Ste 102, Laurel, MD 20708 Phone: 301-498-8100 Fax: 301-498-0009 |
Sharone Lerner Cheskis Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13200 Larchdale Rd, Laurel, MD 20708 Phone: 301-497-3650 |
Ms. Rohini Honnappa, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11051 Birchtree Ln, Laurel, MD 20723 Phone: 240-441-1266 |
Mrs. Tatevik Ananyan Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 14409 Greenview Dr Ste 102, Laurel, MD 20708 Phone: 301-498-8100 Fax: 301-498-0009 |
News Archive
Sensing pain is extremely unpleasant and sometimes hard to bear - and pain can even become chronic. The perception of pain varies a lot depending on the context in which it is experienced. 50 years ago, neurobiologist Patrick Wall and psychologist Ronald Melzack formulated the so-called "Gate Control Theory" of pain.
How do genes control us? This fundamental question of life still remains elusive despite decades of research. Genes are blueprints for proteins, but it is the proteins that actually carry out vital functions in the body for maintaining life. Diseases such as cancer are not only characterized by altered genes, but also by disturbed protein production.
Accuray Incorporated, a global leader in the field of radiosurgery, announced today financial results for the third quarter of fiscal year 2010, ended March 31, 2010.
Senesco Technologies, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's lead drug candidate SNS01-T for treatment of multiple myeloma.
The State Department on Monday released its 5th annual Senator Paul Simon Water for the Poor Act report (.pdf) to Congress detailing "U.S. efforts to expand access to safe drinking water and sanitation, improve water resources management and increase water productivity in developing countries," NAN/234NEXT.com reports (8/17).
› Verified 3 days ago